Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) reported a net profit attributable to shareholders of 105.6 million yuan for the quarter ended Sept. 30, a 13.13% decrease from the prior-year period, according to a Friday filing with the Hong Kong bourse.
Earnings per share were 0.45 yuan, an 11.76% drop from a year ago.
The revenue for the quarter was 670.4 million yuan, 0.22% more than the previous year's quarter.
The company's shares were down by almost 11% in recent trading.
Price (HKD): $30.25, Change: $-3.7, Percent Change: -10.77%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。